Detalhe da pesquisa
1.
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).
Ann Rheum Dis
; 83(4): 421-428, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071508
2.
Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA).
J Rheumatol
; 51(5): 479-487, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359937
3.
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries.
Ann Rheum Dis
; 82(2): 175-181, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36100351
4.
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration.
Ann Rheum Dis
; 81(10): 1358-1366, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705376
5.
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries.
Rheumatology (Oxford)
; 60(2): 820-828, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810263
6.
Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada.
Rheumatol Int
; 37(7): 1111-1123, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28560470
7.
The challenge of indication extrapolation for infliximab biosimilars.
Biologicals
; 42(4): 177-83, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24962198
8.
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies.
Joint Bone Spine
; 91(2): 105671, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38042363
9.
Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study.
Ann Rheum Dis
; 72(10): 1621-7, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23065731
10.
Real-World Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network.
J Rheumatol
; 50(5): 634-640, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642434
11.
Real-World Retention and Clinical Effectiveness of Secukinumab for Psoriatic Arthritis: Results From the Canadian Spondyloarthritis Research Network.
J Rheumatol
; 50(5): 641-648, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521913
12.
Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada.
BMJ Open
; 13(3): e063198, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878650
13.
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study.
Arthritis Care Res (Hoboken)
; 75(2): 240-251, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678771
14.
Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts.
J Rheumatol
; 49(1): 16-25, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34334357
15.
Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation.
Ann Rheum Dis
; 70(8): 1382-8, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21551506
16.
Monitoring the transition of patients on biologics in rheumatoid arthritis: Consensus guidance for pharmacists.
Pharm Pract (Granada)
; 19(3): 2377, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34621449
17.
Cost-utility analysis of second-line therapy with rituximab compared to tumour necrosis factor inhibitors in rheumatoid arthritis.
Curr Med Res Opin
; 37(1): 157-166, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33136462
18.
Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry.
BMC Rheumatol
; 4: 46, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32968710
19.
Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry.
Arthritis Res Ther
; 21(1): 138, 2019 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171024
20.
Transdermal fentanyl improves pain control and functionality in patients with osteoarthritis: an open-label Canadian trial.
Clin Rheumatol
; 27(5): 587-95, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18038178